Additional information
| Active substance | Cabergoline |
|---|---|
| Trade name | Dostinex, Cabaser |
| Side effects | Nausea, headache, dizziness, orthostatic hypotension, constipation, and fatigue |
| Effects | Decreases serum prolactin levels, can enhance mood, libido, and muscle growth indirectly by reducing prolactin |
| Dosage (sports) | 0.25 mg to 0.5 mg per week |
| Dosage (medical) | 0.25 mg to 1 mg twice a week |
| Half-life | 63 to 69 hours |
| Main action | Inhibits prolactin secretion in the pituitary's lactotroph cells |
| Substance class | Ergoline derivative, Dopamine D2 receptor agonist |
| Formula | C26H37N5O2 |
| Chemical name | Cabergoline |
| Storage conditions | Store at room temperature away from moisture and heat |
| Blood pressure | Can cause hypotension |
| WAREHOUSE | International Warehouse 2 |
| Also known as | Cabergoline |
| Lab Test | Prolactin levels |
| Aromatization | No |
| Hepatotoxicity | No |
| HBR | No |
| Water Retention | No |
| Acne | No |
| Dosage | 1-2 mg/week |
| Classification | Prolactin inhibitor |
| Active Half-Life | 63-68 hours |
| Use in sports | Used by athletes to counteract prolactin-related side effects of certain steroids and performance-enhancing drugs |
| Manufacturer | Pfizer |
Reviews
There are no reviews yet.